ID   S26A4_HUMAN             Reviewed;         780 AA.
AC   O43511; B7Z266; O43170;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   12-APR-2017, entry version 169.
DE   RecName: Full=Pendrin;
DE   AltName: Full=Sodium-independent chloride/iodide transporter;
DE   AltName: Full=Solute carrier family 26 member 4;
GN   Name=SLC26A4; Synonyms=PDS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PDS CYS-667.
RC   TISSUE=Thyroid;
RX   PubMed=9398842; DOI=10.1038/ng1297-411;
RA   Everett L.A., Glaser B., Beck J.C., Idol J.R., Buchs A., Heyman M.,
RA   Adawi F., Hazani E., Nassir E., Baxevanis A.D., Sheffield V.C.,
RA   Green E.D.;
RT   "Pendred syndrome is caused by mutations in a putative sulphate
RT   transporter gene (PDS).";
RL   Nat. Genet. 17:411-422(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   FUNCTION.
RX   PubMed=10192399; DOI=10.1038/7783;
RA   Scott D.A., Wang R., Kreman T.M., Sheffield V.C., Karnishki L.P.;
RT   "The Pendred syndrome gene encodes a chloride-iodide transport
RT   protein.";
RL   Nat. Genet. 21:440-443(1999).
RN   [5]
RP   VARIANTS PDS PHE-138; ALA-139; VAL-209; PRO-236; HIS-271; HIS-409;
RP   PRO-416; TRP-445; TYR-565 AND ARG-723.
RX   PubMed=9618166; DOI=10.1093/hmg/7.7.1099;
RA   van Hauwe P., Everett L.A., Coucke P., Scott D.A., Kraft M.L.,
RA   Ris-Stalpers C., Bolder C., Otten B., de Vijlder J.J.M.,
RA   Dietrich N.L., Ramesh A., Srisailapathy S.C.R., Parving A.,
RA   Cremers C.W.R.J., Willems P.J., Smith R.J.H., Green E.D., van Camp G.;
RT   "Two frequent missense mutations in Pendred syndrome.";
RL   Hum. Mol. Genet. 7:1099-1104(1998).
RN   [6]
RP   VARIANTS PDS PHE-138; PRO-236; GLY-384; HIS-409; MET-410; PRO-416;
RP   HIS-530; CYS-556 AND GLU-672.
RX   PubMed=9618167; DOI=10.1093/hmg/7.7.1105;
RA   Coyle B., Reardon W., Herbrick J.-A., Tsui L.-C., Gausden E., Lee J.,
RA   Coffey R., Grueters A., Grossman A., Phelps P.D., Luxon L.,
RA   Kendall-Taylor P., Scherer S.W., Trembath R.C.;
RT   "Molecular analysis of the PDS gene in Pendred syndrome (sensorineural
RT   hearing loss and goitre).";
RL   Hum. Mol. Genet. 7:1105-1112(1998).
RN   [7]
RP   VARIANTS DFNB4 LEU-490 AND SER-497.
RX   PubMed=9500541; DOI=10.1038/ng0398-215;
RA   Li X.C., Everett L.A., Lalwani A.K., Desmukh D., Friedman T.B.,
RA   Green E.D., Wilcox E.R.;
RT   "A mutation in PDS causes non-syndromic recessive deafness.";
RL   Nat. Genet. 18:215-217(1998).
RN   [8]
RP   VARIANTS DFNB4 VAL-209; GLU-369; VAL-372; MET-721 AND ARG-723.
RX   PubMed=10190331; DOI=10.1007/s004390050933;
RA   Usami S., Abe S., Weston M.D., Shinkawa H., Van Camp G.,
RA   Kimberling W.J.;
RT   "Non-syndromic hearing loss associated with enlarged vestibular
RT   aqueduct is caused by PDS mutations.";
RL   Hum. Genet. 104:188-192(1999).
RN   [9]
RP   VARIANT PDS TRP-445.
RX   PubMed=10602116;
RX   DOI=10.1002/(SICI)1096-8628(20000103)90:1<38::AID-AJMG8>3.3.CO;2-I;
RA   Masmoudi S., Charfedine I., Hmani M., Grati M., Ghorbel A.M.,
RA   Elgaied-Boulila A., Drira M., Hardelin J.-P., Ayadi M.;
RT   "Pendred syndrome: phenotypic variability in two families carrying the
RT   same PDS missense mutation.";
RL   Am. J. Med. Genet. 90:38-44(2000).
RN   [10]
RP   VARIANT PDS ASN-508.
RX   PubMed=10718825; DOI=10.1046/j.1365-2265.2000.00930.x;
RA   Bogazzi F., Raggi F., Ultimieri F., Campomori A., Cosci C.,
RA   Berrettini S., Neri E., La Rocca R., Ronca G., Martino E.,
RA   Bartalena L.;
RT   "A novel mutation in the pendrin gene associated with Pendred's
RT   syndrome.";
RL   Clin. Endocrinol. (Oxf.) 52:279-285(2000).
RN   [11]
RP   VARIANT PDS ILE-193.
RX   PubMed=10878664; DOI=10.1038/sj.ejhg.5200489;
RA   Adato A., Raskin L., Petit C., Bonne-Tamir B.;
RT   "Deafness heterogeneity in a Druze isolate from the Middle East: novel
RT   OTOF and PDS mutations, low prevalence of GJB2 35delG mutation and
RT   indication for a new DFNB locus.";
RL   Eur. J. Hum. Genet. 8:437-442(2000).
RN   [12]
RP   VARIANTS DFNB4 PHE-117; VAL-209; PRO-236; MET-410; PRO-416; TRP-445
RP   AND ARG-446.
RX   PubMed=10700480; DOI=10.1093/qjmed/93.2.99;
RA   Reardon W., O'Mahoney C.F., Trembath R., Jan H., Phelps P.D.;
RT   "Enlarged vestibular aqueduct: a radiological marker of Pendred
RT   syndrome, and mutation of the PDS gene.";
RL   QJM 93:99-104(2000).
RN   [13]
RP   VARIANTS PDS PHE-138 AND PRO-411.
RX   PubMed=11375792; DOI=10.1530/eje.0.1440585;
RA   Gonzalez Trevino O., Karamanoglu Arseven O., Ceballos C.J.,
RA   Vives V.I., Ramirez R.C., Gomez V.V., Medeiros-Neto G., Kopp P.;
RT   "Clinical and molecular analysis of three Mexican families with
RT   Pendred's syndrome.";
RL   Eur. J. Endocrinol. 144:585-593(2001).
RN   [14]
RP   VARIANTS PDS GLN-29; CYS-105; ASP-106; PHE-138; VAL-209; PRO-236;
RP   LEU-335; PRO-416; ASP-480; HIS-530; ALA-653 AND GLU-672, AND VARIANT
RP   SER-597.
RX   PubMed=11317356; DOI=10.1002/humu.1116;
RA   Campbell C., Cucci R.A., Prasad S., Green G.E., Edeal J.B.,
RA   Galer C.E., Karniski L.P., Sheffield V.C., Smith R.J.H.;
RT   "Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight
RT   novel mutations and possible genotype-phenotype correlations.";
RL   Hum. Mutat. 17:403-411(2001).
RN   [15]
RP   VARIANTS PDS TRP-445; HIS-556 AND MET-721, AND VARIANTS DFNB4 ILE-132
RP   AND MET-410.
RX   PubMed=11748854; DOI=10.1002/humu.1238;
RA   Lopez-Bigas N., Melchionda S., de Cid R., Grifa A., Zelante L.,
RA   Govea N., Arbones M.L., Gasparini P., Estivill X.;
RT   "Identification of five new mutations of PDS/SLC26A4 in Mediterranean
RT   families with hearing impairment.";
RL   Hum. Mutat. 18:548-548(2001).
RN   [16]
RP   ERRATUM.
RX   PubMed=12112665; DOI=10.1002/humu.9043;
RA   Lopez-Bigas N., Melchionda S., de Cid R., Grifa A., Zelante L.,
RA   Govea N., Arbones M.L., Gasparini P., Estivill X.;
RL   Hum. Mutat. 20:77-78(2002).
RN   [17]
RP   CHARACTERIZATION OF VARIANTS PDS ARG-102; PHE-117; PHE-138; VAL-209;
RP   PRO-236; MET-410; ARG-446; CYS-556 AND GLU-672.
RX   PubMed=11932316; DOI=10.1210/jcem.87.4.8435;
RA   Taylor J.P., Metcalfe R.A., Watson P.F., Weetman A.P., Trembath R.C.;
RT   "Mutations of the PDS gene, encoding pendrin, are associated with
RT   protein mislocalization and loss of iodide efflux: implications for
RT   thyroid dysfunction in Pendred syndrome.";
RL   J. Clin. Endocrinol. Metab. 87:1778-1784(2002).
RN   [18]
RP   VARIANTS PDS ARG-28; THR-133; HIS-409 AND MET-410, AND VARIANT
RP   SER-597.
RX   PubMed=11919333; DOI=10.1203/00006450-200204000-00013;
RA   Fugazzola L., Cerutti N., Mannavola D., Crino A., Cassio A.,
RA   Gasparoni P., Vannucchi G., Beck-Peccoz P.;
RT   "Differential diagnosis between Pendred and pseudo-Pendred syndromes:
RT   clinical, radiologic, and molecular studies.";
RL   Pediatr. Res. 51:479-484(2002).
RN   [19]
RP   VARIANTS PDS ASP-239 AND ARG-723.
RX   PubMed=12974744; DOI=10.1034/j.1399-0004.2003.00144.x;
RA   Tekin M., Akcayoez D., Comak E., Bogoclu G., Duman T., Fitoz S.,
RA   Ilhan I., Akar N.;
RT   "Screening the SLC26A4 gene in probands with deafness and goiter
RT   (Pendred syndrome) ascertained from a large group of students of the
RT   schools for the deaf in Turkey.";
RL   Clin. Genet. 64:371-374(2003).
RN   [20]
RP   VARIANTS DFNB4 SER-123; VAL-147 AND PHE-666.
RX   PubMed=14508505; DOI=10.1038/sj.ejhg.5201073;
RA   Tsukamoto K., Suzuki H., Harada D., Namba A., Abe S., Usami S.;
RT   "Distribution and frequencies of PDS (SLC26A4) mutations in Pendred
RT   syndrome and nonsyndromic hearing loss associated with enlarged
RT   vestibular aqueduct: a unique spectrum of mutations in Japanese.";
RL   Eur. J. Hum. Genet. 11:916-922(2003).
RN   [21]
RP   VARIANTS PDS THR-133; PHE-138; GLY-384 AND HIS-530.
RX   PubMed=12788906; DOI=10.1210/jc.2002-021334;
RA   Borck G., Roth C., Martine U., Wildhardt G., Pohlenz J.;
RT   "Mutations in the PDS gene in German families with Pendred's syndrome:
RT   V138F is a founder mutation.";
RL   J. Clin. Endocrinol. Metab. 88:2916-2921(2003).
RN   [22]
RP   VARIANTS DFNB4 ARG-28; LEU-90; ASP-239; PRO-252; TYR-392; PRO-409;
RP   MET-410; LYS-457; GLN-676; MET-721 AND ARG-723, AND VARIANT PHE-455.
RX   PubMed=12676893; DOI=10.1136/jmg.40.4.242;
RA   Park H.-J., Shaukat S., Liu X.-Z., Hahn S.H., Naz S., Ghosh M.,
RA   Kim H.-N., Moon S.-K., Abe S., Tukamoto K., Riazuddin S., Kabra M.,
RA   Erdenetungalag R., Radnaabazar J., Khan S., Pandya A., Usami S.,
RA   Nance W.E., Wilcox E.R., Riazuddin S., Griffith A.J.;
RT   "Origins and frequencies of SLC26A4 (PDS) mutations in east and south
RT   Asians: global implications for the epidemiology of deafness.";
RL   J. Med. Genet. 40:242-248(2003).
RN   [23]
RP   VARIANTS PDS/DFNB4 GLY-24; GLN-29; CYS-78; VAL-104; CYS-105; ASP-106;
RP   PHE-138; ALA-139; VAL-209; PRO-236; HIS-271; LEU-335; GLY-384;
RP   HIS-409; MET-410; PRO-416; ARG-421; ALA-429 DEL; TRP-445; ASP-480;
RP   HIS-530; CYS-556; TYR-565; ALA-653; GLU-672; SER-683 AND ARG-723, AND
RP   VARIANTS TYR-324 AND SER-597.
RX   PubMed=14679580; DOI=10.1002/ajmg.a.20272;
RA   Prasad S., Koelln K.A., Cucci R.A., Trembath R.C., Van Camp G.,
RA   Smith R.J.H.;
RT   "Pendred syndrome and DFNB4-mutation screening of SLC26A4 by
RT   denaturing high-performance liquid chromatography and the
RT   identification of eleven novel mutations.";
RL   Am. J. Med. Genet. A 124:1-9(2004).
RN   [24]
RP   VARIANTS PDS GLN-29; CYS-78; PRO-137; PHE-138; ILE-193; VAL-209;
RP   PRO-236; ASN-391; HIS-409; MET-410; PRO-416; TRP-445; HIS-530;
RP   ILE-552; PRO-694; MET-721 AND ASN-724, AND VARIANT SER-597.
RX   PubMed=15355436; DOI=10.1111/j.1399-0004.2004.00296.x;
RA   Blons H., Feldmann D., Duval V., Messaz O., Denoyelle F., Loundon N.,
RA   Sergout-Allaoui A., Houang M., Duriez F., Lacombe D., Delobel B.,
RA   Leman J., Catros H., Journel H., Drouin-Garraud V., Obstoy M.-F.,
RA   Toutain A., Oden S., Toublanc J.E., Couderc R., Petit C.,
RA   Garabedian E.-N., Marlin S.;
RT   "Screening of SLC26A4 (PDS) gene in Pendred's syndrome: a large
RT   spectrum of mutations in France and phenotypic heterogeneity.";
RL   Clin. Genet. 66:333-340(2004).
RN   [25]
RP   VARIANT PDS PRO-416.
RX   PubMed=15531480; DOI=10.1210/jc.2004-1013;
RA   Napiontek U., Borck G., Mueller-Forell W., Pfarr N., Bohnert A.,
RA   Keilmann A., Pohlenz J.;
RT   "Intrafamilial variability of the deafness and goiter phenotype in
RT   Pendred syndrome caused by a T416P mutation in the SLC26A4 gene.";
RL   J. Clin. Endocrinol. Metab. 89:5347-5351(2004).
RN   [26]
RP   VARIANTS PDS ARG-514 AND SER-530, AND VARIANTS GLY-609 AND CYS-776.
RX   PubMed=15689455; DOI=10.1136/jmg.2004.024208;
RA   Pryor S.P., Madeo A.C., Reynolds J.C., Sarlis N.J., Arnos K.S.,
RA   Nance W.E., Yang Y., Zalewski C.K., Brewer C.C., Butman J.A.,
RA   Griffith A.J.;
RT   "SLC26A4/PDS genotype-phenotype correlation in hearing loss with
RT   enlargement of the vestibular aqueduct (EVA): evidence that Pendred
RT   syndrome and non-syndromic EVA are distinct clinical and genetic
RT   entities.";
RL   J. Med. Genet. 42:159-165(2005).
RN   [27]
RP   VARIANT CYS-776, AND CHARACTERIZATION OF VARIANT CYS-776.
RX   PubMed=16684826; DOI=10.1210/jc.2006-0142;
RA   Pfarr N., Borck G., Turk A., Napiontek U., Keilmann A.,
RA   Mueller-Forell W., Kopp P., Pohlenz J.;
RT   "Goitrous congenital hypothyroidism and hearing impairment associated
RT   with mutations in the TPO and SLC26A4/PDS genes.";
RL   J. Clin. Endocrinol. Metab. 91:2678-2681(2006).
RN   [28]
RP   VARIANT MET-99.
RX   PubMed=17146393; DOI=10.1097/01.mlg.0000244389.68568.a7;
RA   Propst E.J., Blaser S., Stockley T.L., Harrison R.V., Gordon K.A.,
RA   Papsin B.C.;
RT   "Temporal bone imaging in GJB2 deafness.";
RL   Laryngoscope 116:2178-2186(2006).
RN   [29]
RP   VARIANTS PDS PHE-138; VAL-209; PRO-236; GLY-384; MET-402; PRO-416;
RP   TRP-445; ARG-514; HIS-530; TYR-565 AND THR-775, VARIANTS DFNB4
RP   LEU-335; MET-402; SER-530 AND THR-775, AND VARIANTS SER-597; GLY-609
RP   AND CYS-776.
RX   PubMed=19204907; DOI=10.1002/humu.20884;
RA   Choi B.Y., Stewart A.K., Madeo A.C., Pryor S.P., Lenhard S.,
RA   Kittles R., Eisenman D., Kim H.J., Niparko J., Thomsen J., Arnos K.S.,
RA   Nance W.E., King K.A., Zalewski C.K., Brewer C.C., Shawker T.,
RA   Reynolds J.C., Butman J.A., Karniski L.P., Alper S.L., Griffith A.J.;
RT   "Hypo-functional SLC26A4 variants associated with nonsyndromic hearing
RT   loss and enlargement of the vestibular aqueduct: genotype-phenotype
RT   correlation or coincidental polymorphisms?";
RL   Hum. Mutat. 30:599-608(2009).
RN   [30]
RP   VARIANT DFNB4 ILE-281, AND VARIANTS VAL-6; ALA-144; THR-185 AND
RP   SER-597.
RX   PubMed=20597900; DOI=10.1111/j.1469-1809.2010.00581.x;
RA   Pourova R., Janousek P., Jurovcik M., Dvorakova M., Malikova M.,
RA   Raskova D., Bendova O., Leonardi E., Murgia A., Kabelka Z., Astl J.,
RA   Seeman P.;
RT   "Spectrum and frequency of SLC26A4 mutations among Czech patients with
RT   early hearing loss with and without enlarged vestibular aqueduct
RT   (EVA).";
RL   Ann. Hum. Genet. 74:299-307(2010).
RN   [31]
RP   VARIANT DFNB4 LYS-558.
RX   PubMed=20108392;
RA   Alasti F., Peeters N., Wuyts W., Sanati M.H., Van Camp G.;
RT   "Novel human pathological mutations. Gene symbol: SLC26A4. Disease:
RT   Deafness, non-syndromic, autosomal recessive.";
RL   Hum. Genet. 127:116-116(2010).
RN   [32]
RP   VARIANT PHE-455.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E.,
RA   Fennell T., O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B.,
RA   Tukiainen T., Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K.,
RA   Zhao F., Zou J., Pierce-Hoffman E., Berghout J., Cooper D.N.,
RA   Deflaux N., DePristo M., Do R., Flannick J., Fromer M., Gauthier L.,
RA   Goldstein J., Gupta N., Howrigan D., Kiezun A., Kurki M.I.,
RA   Moonshine A.L., Natarajan P., Orozco L., Peloso G.M., Poplin R.,
RA   Rivas M.A., Ruano-Rubio V., Rose S.A., Ruderfer D.M., Shakir K.,
RA   Stenson P.D., Stevens C., Thomas B.P., Tiao G., Tusie-Luna M.T.,
RA   Weisburd B., Won H.H., Yu D., Altshuler D.M., Ardissino D.,
RA   Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S.,
RA   Laakso M., McCarroll S., McCarthy M.I., McGovern D., McPherson R.,
RA   Neale B.M., Palotie A., Purcell S.M., Saleheen D., Scharf J.M.,
RA   Sklar P., Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C.,
RA   Wilson J.G., Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: Sodium-independent transporter of chloride and iodide.
CC       {ECO:0000269|PubMed:10192399}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Cell membrane; Multi-pass membrane protein.
CC       Note=Localizes to the apical brush border of cells in the cortical
CC       collecting ducts of the kidney. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43511-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43511-2; Sequence=VSP_056688;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High expression in adult thyroid, lower
CC       expression in adult and fetal kidney and fetal brain. Not
CC       expressed in other tissues.
CC   -!- DISEASE: Pendred syndrome (PDS) [MIM:274600]: An autosomal
CC       recessive disorder characterized by congenital sensorineural
CC       hearing loss in association with thyroid goiter. The disorder may
CC       account for up to 10% of the cases of hereditary deafness. The
CC       deafness is most often associated with a Mondini cochlear defect.
CC       Deafness occurs early, starting at birth or during the first years
CC       of life. It is bilateral, sometimes asymmetrical, fluctuant and
CC       often progressive. Thyroid perturbations, such as thyroid goiter
CC       and/or hypothyroidism appear most commonly during adolescence, but
CC       they can be congenital or appear later.
CC       {ECO:0000269|PubMed:10602116, ECO:0000269|PubMed:10718825,
CC       ECO:0000269|PubMed:10878664, ECO:0000269|PubMed:11317356,
CC       ECO:0000269|PubMed:11375792, ECO:0000269|PubMed:11748854,
CC       ECO:0000269|PubMed:11919333, ECO:0000269|PubMed:11932316,
CC       ECO:0000269|PubMed:12788906, ECO:0000269|PubMed:12974744,
CC       ECO:0000269|PubMed:14679580, ECO:0000269|PubMed:15355436,
CC       ECO:0000269|PubMed:15531480, ECO:0000269|PubMed:15689455,
CC       ECO:0000269|PubMed:19204907, ECO:0000269|PubMed:9398842,
CC       ECO:0000269|PubMed:9618166, ECO:0000269|PubMed:9618167}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Deafness, autosomal recessive, 4 (DFNB4) [MIM:600791]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner
CC       ear, the nerve pathways to the brain, or the area of the brain
CC       that receives sound information. DFNB4 is associated with an
CC       enlarged vestibular aqueduct. {ECO:0000269|PubMed:10190331,
CC       ECO:0000269|PubMed:10700480, ECO:0000269|PubMed:11748854,
CC       ECO:0000269|PubMed:12676893, ECO:0000269|PubMed:14508505,
CC       ECO:0000269|PubMed:14679580, ECO:0000269|PubMed:19204907,
CC       ECO:0000269|PubMed:20108392, ECO:0000269|PubMed:20597900,
CC       ECO:0000269|PubMed:9500541}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SLC26A/SulP transporter (TC 2.A.53)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Hereditary hearing loss homepage; Note=Gene
CC       page;
CC       URL="http://hereditaryhearingloss.org/main.aspx?c=.HHH&n=86162";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=S&genename=SLC26A4+%40+PDS";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Pendrin entry;
CC       URL="https://en.wikipedia.org/wiki/Pendrin";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=A missing sense - Issue
CC       133 of November 2011;
CC       URL="http://web.expasy.org/spotlight/back_issues/133";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF030880; AAC51873.1; -; mRNA.
DR   EMBL; AK294388; BAH11752.1; -; mRNA.
DR   EMBL; AC002467; AAB88773.2; -; Genomic_DNA.
DR   EMBL; AC078937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS5746.1; -. [O43511-1]
DR   RefSeq; NP_000432.1; NM_000441.1. [O43511-1]
DR   RefSeq; XP_005250482.1; XM_005250425.2. [O43511-1]
DR   UniGene; Hs.571246; -.
DR   ProteinModelPortal; O43511; -.
DR   STRING; 9606.ENSP00000265715; -.
DR   TCDB; 2.A.53.2.17; the sulfate permease (sulp) family.
DR   iPTMnet; O43511; -.
DR   PhosphoSitePlus; O43511; -.
DR   BioMuta; SLC26A4; -.
DR   EPD; O43511; -.
DR   PaxDb; O43511; -.
DR   PeptideAtlas; O43511; -.
DR   PRIDE; O43511; -.
DR   DNASU; 5172; -.
DR   Ensembl; ENST00000265715; ENSP00000265715; ENSG00000091137. [O43511-1]
DR   GeneID; 5172; -.
DR   KEGG; hsa:5172; -.
DR   UCSC; uc003vep.4; human. [O43511-1]
DR   CTD; 5172; -.
DR   DisGeNET; 5172; -.
DR   GeneCards; SLC26A4; -.
DR   GeneReviews; SLC26A4; -.
DR   H-InvDB; HIX0006991; -.
DR   HGNC; HGNC:8818; SLC26A4.
DR   HPA; HPA042860; -.
DR   MalaCards; SLC26A4; -.
DR   MIM; 274600; phenotype.
DR   MIM; 600791; phenotype.
DR   MIM; 605646; gene.
DR   neXtProt; NX_O43511; -.
DR   OpenTargets; ENSG00000091137; -.
DR   Orphanet; 95713; Athyreosis.
DR   Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB.
DR   Orphanet; 705; Pendred syndrome.
DR   Orphanet; 95720; Thyroid hypoplasia.
DR   PharmGKB; PA35506; -.
DR   eggNOG; KOG0236; Eukaryota.
DR   eggNOG; COG0659; LUCA.
DR   GeneTree; ENSGT00760000119026; -.
DR   HOGENOM; HOG000006546; -.
DR   HOVERGEN; HBG000639; -.
DR   InParanoid; O43511; -.
DR   KO; K14702; -.
DR   OMA; PSWNGLG; -.
DR   OrthoDB; EOG091G07RT; -.
DR   PhylomeDB; O43511; -.
DR   TreeFam; TF313784; -.
DR   Reactome; R-HSA-427601; Multifunctional anion exchangers.
DR   ChiTaRS; SLC26A4; human.
DR   GeneWiki; Pendrin; -.
DR   GenomeRNAi; 5172; -.
DR   PRO; PR:O43511; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000091137; -.
DR   CleanEx; HS_SLC26A4; -.
DR   ExpressionAtlas; O43511; baseline and differential.
DR   Genevisible; O43511; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015301; F:anion:anion antiporter activity; IBA:GO_Central.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0015108; F:chloride transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015111; F:iodide transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0019531; F:oxalate transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0015116; F:sulfate transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015701; P:bicarbonate transport; IBA:GO_Central.
DR   GO; GO:0015698; P:inorganic anion transport; TAS:ProtInc.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0051453; P:regulation of intracellular pH; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0006885; P:regulation of pH; ISS:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; ISS:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0008272; P:sulfate transport; TAS:ProtInc.
DR   Gene3D; 3.30.750.24; -; 1.
DR   InterPro; IPR030285; Pendrin.
DR   InterPro; IPR018045; S04_transporter_CS.
DR   InterPro; IPR011547; SLC26A/SulP_dom.
DR   InterPro; IPR001902; SLC26A/SulP_fam.
DR   InterPro; IPR002645; STAS_dom.
DR   PANTHER; PTHR11814; PTHR11814; 1.
DR   PANTHER; PTHR11814:SF157; PTHR11814:SF157; 1.
DR   Pfam; PF01740; STAS; 1.
DR   Pfam; PF00916; Sulfate_transp; 1.
DR   SUPFAM; SSF52091; SSF52091; 2.
DR   TIGRFAMs; TIGR00815; sulP; 1.
DR   PROSITE; PS01130; SLC26A; 1.
DR   PROSITE; PS50801; STAS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Chloride; Complete proteome;
KW   Deafness; Disease mutation; Membrane; Non-syndromic deafness;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    780       Pendrin.
FT                                /FTId=PRO_0000080164.
FT   TOPO_DOM      1     87       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical. {ECO:0000255}.
FT   TOPO_DOM    109    109       Extracellular. {ECO:0000255}.
FT   TRANSMEM    110    130       Helical. {ECO:0000255}.
FT   TOPO_DOM    131    135       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    136    156       Helical. {ECO:0000255}.
FT   TOPO_DOM    157    191       Extracellular. {ECO:0000255}.
FT   TRANSMEM    192    212       Helical. {ECO:0000255}.
FT   TOPO_DOM    213    218       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TOPO_DOM    240    263       Extracellular. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    295       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    296    316       Helical. {ECO:0000255}.
FT   TOPO_DOM    317    344       Extracellular. {ECO:0000255}.
FT   TRANSMEM    345    365       Helical. {ECO:0000255}.
FT   TOPO_DOM    366    384       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    385    405       Helical. {ECO:0000255}.
FT   TOPO_DOM    406    421       Extracellular. {ECO:0000255}.
FT   TRANSMEM    422    442       Helical. {ECO:0000255}.
FT   TOPO_DOM    443    448       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    449    469       Helical. {ECO:0000255}.
FT   TOPO_DOM    470    486       Extracellular. {ECO:0000255}.
FT   TRANSMEM    487    507       Helical. {ECO:0000255}.
FT   TOPO_DOM    508    780       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      535    729       STAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00198}.
FT   VAR_SEQ       1    431       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056688.
FT   VARIANT       6      6       G -> V (in dbSNP:rs111033423).
FT                                {ECO:0000269|PubMed:20597900}.
FT                                /FTId=VAR_064988.
FT   VARIANT      24     24       R -> G (in Pendred syndrome/deafness
FT                                individuals).
FT                                {ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021638.
FT   VARIANT      28     28       S -> R (in PDS and DFNB4;
FT                                dbSNP:rs539699299).
FT                                {ECO:0000269|PubMed:11919333,
FT                                ECO:0000269|PubMed:12676893}.
FT                                /FTId=VAR_021639.
FT   VARIANT      29     29       E -> Q (in PDS; dbSNP:rs111033205).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_021640.
FT   VARIANT      78     78       Y -> C (in PDS).
FT                                {ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_021641.
FT   VARIANT      90     90       S -> L (in DFNB4; dbSNP:rs370588279).
FT                                {ECO:0000269|PubMed:12676893}.
FT                                /FTId=VAR_021642.
FT   VARIANT      99     99       T -> M (in dbSNP:rs141142414).
FT                                {ECO:0000269|PubMed:17146393}.
FT                                /FTId=VAR_064989.
FT   VARIANT     102    102       G -> R (in PDS; fails to localize to cell
FT                                membrane; abolishes iodide transport).
FT                                {ECO:0000269|PubMed:11932316}.
FT                                /FTId=VAR_021643.
FT   VARIANT     104    104       A -> V (in Pendred syndrome/deafness
FT                                individuals).
FT                                {ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021644.
FT   VARIANT     105    105       Y -> C (in PDS).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021645.
FT   VARIANT     106    106       A -> D (in PDS).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021646.
FT   VARIANT     117    117       L -> F (in DFNB4 and PDS; does not affect
FT                                protein localization to cell membrane;
FT                                does not affect iodide transport;
FT                                dbSNP:rs145254330).
FT                                {ECO:0000269|PubMed:10700480,
FT                                ECO:0000269|PubMed:11932316}.
FT                                /FTId=VAR_021647.
FT   VARIANT     123    123       P -> S (in DFNB4).
FT                                {ECO:0000269|PubMed:14508505}.
FT                                /FTId=VAR_027238.
FT   VARIANT     132    132       T -> I (in DFNB4).
FT                                {ECO:0000269|PubMed:11748854}.
FT                                /FTId=VAR_021648.
FT   VARIANT     133    133       S -> T (in PDS; dbSNP:rs121908365).
FT                                {ECO:0000269|PubMed:11919333,
FT                                ECO:0000269|PubMed:12788906}.
FT                                /FTId=VAR_021649.
FT   VARIANT     137    137       S -> P (in PDS).
FT                                {ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_021650.
FT   VARIANT     138    138       V -> F (in PDS; fails to localize to cell
FT                                membrane; abolishes iodide transport;
FT                                dbSNP:rs111033199).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:11375792,
FT                                ECO:0000269|PubMed:11932316,
FT                                ECO:0000269|PubMed:12788906,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618166,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_021651.
FT   VARIANT     139    139       G -> A (in PDS).
FT                                {ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:9618166}.
FT                                /FTId=VAR_021652.
FT   VARIANT     144    144       V -> A (found at heterozygosity in a
FT                                patient with non-syndromic deafness;
FT                                uncertain pathological significance;
FT                                dbSNP:rs772023020).
FT                                {ECO:0000269|PubMed:20597900}.
FT                                /FTId=VAR_064990.
FT   VARIANT     147    147       M -> V (in DFNB4; dbSNP:rs760413427).
FT                                {ECO:0000269|PubMed:14508505}.
FT                                /FTId=VAR_027239.
FT   VARIANT     185    185       R -> T (found at heterozygosity in a
FT                                patient with non-syndromic deafness;
FT                                uncertain pathological significance;
FT                                dbSNP:rs542620119).
FT                                {ECO:0000269|PubMed:20597900}.
FT                                /FTId=VAR_064991.
FT   VARIANT     193    193       T -> I (in PDS; dbSNP:rs111033348).
FT                                {ECO:0000269|PubMed:10878664,
FT                                ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_011623.
FT   VARIANT     209    209       G -> V (in DFNB4 and PDS; severely
FT                                reduces iodide transport without
FT                                affecting protein localization to cell
FT                                membrane; dbSNP:rs111033303).
FT                                {ECO:0000269|PubMed:10190331,
FT                                ECO:0000269|PubMed:10700480,
FT                                ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:11932316,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618166}.
FT                                /FTId=VAR_007440.
FT   VARIANT     236    236       L -> P (in PDS and DFNB4; common
FT                                mutation; fails to localize to cell
FT                                membrane; abolishes iodide transport;
FT                                dbSNP:rs80338848).
FT                                {ECO:0000269|PubMed:10700480,
FT                                ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:11932316,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618166,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_007441.
FT   VARIANT     239    239       V -> D (in PDS and DFNB4;
FT                                dbSNP:rs111033256).
FT                                {ECO:0000269|PubMed:12676893,
FT                                ECO:0000269|PubMed:12974744}.
FT                                /FTId=VAR_021653.
FT   VARIANT     252    252       S -> P (in DFNB4).
FT                                {ECO:0000269|PubMed:12676893}.
FT                                /FTId=VAR_021654.
FT   VARIANT     271    271       D -> H (in PDS).
FT                                {ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:9618166}.
FT                                /FTId=VAR_021655.
FT   VARIANT     281    281       V -> I (in DFNB4; dbSNP:rs727505080).
FT                                {ECO:0000269|PubMed:20597900}.
FT                                /FTId=VAR_064992.
FT   VARIANT     301    301       P -> L (in dbSNP:rs34373141).
FT                                /FTId=VAR_053663.
FT   VARIANT     324    324       N -> Y (in dbSNP:rs36039758).
FT                                {ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_053664.
FT   VARIANT     335    335       F -> L (in PDS and DFNB4;
FT                                dbSNP:rs111033212).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:19204907}.
FT                                /FTId=VAR_021656.
FT   VARIANT     369    369       K -> E (in DFNB4; dbSNP:rs121908361).
FT                                {ECO:0000269|PubMed:10190331}.
FT                                /FTId=VAR_007442.
FT   VARIANT     372    372       A -> V (in DFNB4; dbSNP:rs121908364).
FT                                {ECO:0000269|PubMed:10190331}.
FT                                /FTId=VAR_007443.
FT   VARIANT     384    384       E -> G (in PDS; dbSNP:rs111033244).
FT                                {ECO:0000269|PubMed:12788906,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_007444.
FT   VARIANT     391    391       S -> N (in PDS).
FT                                {ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_021657.
FT   VARIANT     392    392       N -> Y (in DFNB4; dbSNP:rs201562855).
FT                                {ECO:0000269|PubMed:12676893}.
FT                                /FTId=VAR_021658.
FT   VARIANT     402    402       V -> M (in PDS and DFNB4;
FT                                dbSNP:rs397516414).
FT                                {ECO:0000269|PubMed:19204907}.
FT                                /FTId=VAR_058580.
FT   VARIANT     409    409       R -> H (in PDS; dbSNP:rs111033305).
FT                                {ECO:0000269|PubMed:11919333,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:9618166,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_021659.
FT   VARIANT     409    409       R -> P (in DFNB4; dbSNP:rs111033305).
FT                                {ECO:0000269|PubMed:12676893}.
FT                                /FTId=VAR_021660.
FT   VARIANT     410    410       T -> M (in DFNB4 and PDS; fails to
FT                                localize to cell membrane; abolishes
FT                                iodide transport; dbSNP:rs111033220).
FT                                {ECO:0000269|PubMed:10700480,
FT                                ECO:0000269|PubMed:11748854,
FT                                ECO:0000269|PubMed:11919333,
FT                                ECO:0000269|PubMed:11932316,
FT                                ECO:0000269|PubMed:12676893,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_021661.
FT   VARIANT     411    411       A -> P (in PDS).
FT                                {ECO:0000269|PubMed:11375792}.
FT                                /FTId=VAR_021662.
FT   VARIANT     416    416       T -> P (in PDS and DFNB4; common
FT                                mutation; dbSNP:rs28939086).
FT                                {ECO:0000269|PubMed:10700480,
FT                                ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:15531480,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618166,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_007445.
FT   VARIANT     421    421       Q -> R (in Pendred syndrome/deafness
FT                                individuals; dbSNP:rs201660407).
FT                                {ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021663.
FT   VARIANT     429    429       Missing (in Pendred syndrome/deafness
FT                                individuals).
FT                                {ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021664.
FT   VARIANT     445    445       L -> W (in PDS and DFNB4;
FT                                dbSNP:rs111033307).
FT                                {ECO:0000269|PubMed:10602116,
FT                                ECO:0000269|PubMed:10700480,
FT                                ECO:0000269|PubMed:11748854,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618166}.
FT                                /FTId=VAR_011624.
FT   VARIANT     446    446       Q -> R (in DFNB4 and PDS; fails to
FT                                localize to cell membrane; abolishes
FT                                iodide transport; dbSNP:rs768471577).
FT                                {ECO:0000269|PubMed:10700480,
FT                                ECO:0000269|PubMed:11932316}.
FT                                /FTId=VAR_021665.
FT   VARIANT     455    455       I -> F (in dbSNP:rs375576481).
FT                                {ECO:0000269|PubMed:12676893,
FT                                ECO:0000269|PubMed:27535533}.
FT                                /FTId=VAR_021666.
FT   VARIANT     457    457       N -> K (in DFNB4).
FT                                {ECO:0000269|PubMed:12676893}.
FT                                /FTId=VAR_021667.
FT   VARIANT     480    480       V -> D (in PDS; retains residual
FT                                transport function).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021668.
FT   VARIANT     490    490       I -> L (in DFNB4; dbSNP:rs200511789).
FT                                {ECO:0000269|PubMed:9500541}.
FT                                /FTId=VAR_021669.
FT   VARIANT     497    497       G -> S (in DFNB4; dbSNP:rs111033308).
FT                                {ECO:0000269|PubMed:9500541}.
FT                                /FTId=VAR_007446.
FT   VARIANT     508    508       T -> N (in PDS).
FT                                {ECO:0000269|PubMed:10718825}.
FT                                /FTId=VAR_027240.
FT   VARIANT     514    514       Q -> R (in PDS; dbSNP:rs111033316).
FT                                {ECO:0000269|PubMed:15689455,
FT                                ECO:0000269|PubMed:19204907}.
FT                                /FTId=VAR_027241.
FT   VARIANT     530    530       Y -> H (in PDS; dbSNP:rs111033254).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:12788906,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_021670.
FT   VARIANT     530    530       Y -> S (in PDS and DFNB4;
FT                                dbSNP:rs747636919).
FT                                {ECO:0000269|PubMed:15689455,
FT                                ECO:0000269|PubMed:19204907}.
FT                                /FTId=VAR_027242.
FT   VARIANT     552    552       S -> I (in PDS).
FT                                {ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_021671.
FT   VARIANT     556    556       Y -> C (in PDS; partially affects protein
FT                                localization to cell membrane; abolishes
FT                                iodide transport; dbSNP:rs763006761).
FT                                {ECO:0000269|PubMed:11932316,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_021672.
FT   VARIANT     556    556       Y -> H (in PDS).
FT                                {ECO:0000269|PubMed:11748854}.
FT                                /FTId=VAR_021673.
FT   VARIANT     558    558       N -> K (in DFNB4).
FT                                {ECO:0000269|PubMed:20108392}.
FT                                /FTId=VAR_064993.
FT   VARIANT     565    565       C -> Y (in PDS; dbSNP:rs111033257).
FT                                {ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:9618166}.
FT                                /FTId=VAR_021674.
FT   VARIANT     597    597       L -> S (in dbSNP:rs55638457).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:11919333,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:15355436,
FT                                ECO:0000269|PubMed:19204907,
FT                                ECO:0000269|PubMed:20597900}.
FT                                /FTId=VAR_021675.
FT   VARIANT     609    609       V -> G (in dbSNP:rs17154335).
FT                                {ECO:0000269|PubMed:15689455,
FT                                ECO:0000269|PubMed:19204907}.
FT                                /FTId=VAR_027243.
FT   VARIANT     653    653       V -> A (in PDS; retains residual
FT                                transport function).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021676.
FT   VARIANT     666    666       S -> F (in DFNB4).
FT                                {ECO:0000269|PubMed:14508505}.
FT                                /FTId=VAR_027244.
FT   VARIANT     667    667       F -> C (in PDS; dbSNP:rs121908360).
FT                                {ECO:0000269|PubMed:9398842}.
FT                                /FTId=VAR_007447.
FT   VARIANT     672    672       G -> E (in PDS; partially affects protein
FT                                localization to cell membrane; abolishes
FT                                iodide transport; dbSNP:rs111033309).
FT                                {ECO:0000269|PubMed:11317356,
FT                                ECO:0000269|PubMed:11932316,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:9618167}.
FT                                /FTId=VAR_021677.
FT   VARIANT     676    676       L -> Q (in DFNB4; dbSNP:rs111033318).
FT                                {ECO:0000269|PubMed:12676893}.
FT                                /FTId=VAR_021678.
FT   VARIANT     683    683       F -> S (in Pendred syndrome/deafness
FT                                individuals).
FT                                {ECO:0000269|PubMed:14679580}.
FT                                /FTId=VAR_021679.
FT   VARIANT     687    687       D -> Y (in dbSNP:rs35548413).
FT                                /FTId=VAR_053665.
FT   VARIANT     694    694       S -> P (in PDS).
FT                                {ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_021680.
FT   VARIANT     721    721       T -> M (in DFNB4 and PDS;
FT                                dbSNP:rs121908363).
FT                                {ECO:0000269|PubMed:10190331,
FT                                ECO:0000269|PubMed:11748854,
FT                                ECO:0000269|PubMed:12676893,
FT                                ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_007448.
FT   VARIANT     723    723       H -> R (in DFNB4 and PDS; common mutation
FT                                in Korea and Japan; dbSNP:rs121908362).
FT                                {ECO:0000269|PubMed:10190331,
FT                                ECO:0000269|PubMed:12676893,
FT                                ECO:0000269|PubMed:12974744,
FT                                ECO:0000269|PubMed:14679580,
FT                                ECO:0000269|PubMed:9618166}.
FT                                /FTId=VAR_007449.
FT   VARIANT     724    724       D -> N (in PDS).
FT                                {ECO:0000269|PubMed:15355436}.
FT                                /FTId=VAR_021681.
FT   VARIANT     740    740       G -> S (in dbSNP:rs17154353).
FT                                /FTId=VAR_027245.
FT   VARIANT     775    775       M -> T (in PDS and DFNB4).
FT                                {ECO:0000269|PubMed:19204907}.
FT                                /FTId=VAR_058581.
FT   VARIANT     776    776       R -> C (retains its ability to transport
FT                                iodide in vitro; dbSNP:rs111033255).
FT                                {ECO:0000269|PubMed:15689455,
FT                                ECO:0000269|PubMed:16684826,
FT                                ECO:0000269|PubMed:19204907}.
FT                                /FTId=VAR_027246.
SQ   SEQUENCE   780 AA;  85723 MW;  3AEF5D720B155CE0 CRC64;
     MAAPGGRSEP PQLPEYSCSY MVSRPVYSEL AFQQQHERRL QERKTLRESL AKCCSCSRKR
     AFGVLKTLVP ILEWLPKYRV KEWLLSDVIS GVSTGLVATL QGMAYALLAA VPVGYGLYSA
     FFPILTYFIF GTSRHISVGP FPVVSLMVGS VVLSMAPDEH FLVSSSNGTV LNTTMIDTAA
     RDTARVLIAS ALTLLVGIIQ LIFGGLQIGF IVRYLADPLV GGFTTAAAFQ VLVSQLKIVL
     NVSTKNYNGV LSIIYTLVEI FQNIGDTNLA DFTAGLLTIV VCMAVKELND RFRHKIPVPI
     PIEVIVTIIA TAISYGANLE KNYNAGIVKS IPRGFLPPEL PPVSLFSEML AASFSIAVVA
     YAIAVSVGKV YATKYDYTID GNQEFIAFGI SNIFSGFFSC FVATTALSRT AVQESTGGKT
     QVAGIISAAI VMIAILALGK LLEPLQKSVL AAVVIANLKG MFMQLCDIPR LWRQNKIDAV
     IWVFTCIVSI ILGLDLGLLA GLIFGLLTVV LRVQFPSWNG LGSIPSTDIY KSTKNYKNIE
     EPQGVKILRF SSPIFYGNVD GFKKCIKSTV GFDAIRVYNK RLKALRKIQK LIKSGQLRAT
     KNGIISDAVS TNNAFEPDED IEDLEELDIP TKEIEIQVDW NSELPVKVNV PKVPIHSLVL
     DCGAISFLDV VGVRSLRVIV KEFQRIDVNV YFASLQDYVI EKLEQCGFFD DNIRKDTFFL
     TVHDAILYLQ NQVKSQEGQG SILETITLIQ DCKDTLELIE TELTEEELDV QDEAMRTLAS
//
